Navigation Links
GlaxoSmithKline President of North America Pharmaceuticals, Deirdre Connelly, Named 2010 Woman of the Year by the Healthcare Businesswomen's Association
Date:2/16/2010

ars," noted for their accomplishments and contributions to the healthcare industry, will also be presented at the luncheon.

While the HBA annually receives many compelling nominations for the WOTY award, the 2010 HBA nominating committee overwhelmingly agreed that Ms. Connelly's many accomplishments embodied the criteria for Woman of the Year, which includes success in the healthcare industry, strong leadership capabilities, proven mentoring skills, dedication, a commitment to giving back to women, and contributions to the community. Described by others as an approachable and engaged leader, Ms. Connelly is widely recognized by her colleagues as a passionate advocate for mentoring and continuous learning.

"The Healthcare Businesswomen's Association is extremely proud to honor Deirdre Connelly as our 2010 Woman of the Year, and we are inspired by her visionary capabilities in setting a clear path for success in a changing marketplace," said Susan Torroella, president of the Healthcare Businesswomen's Association and COO of MEDEX Global Group. "In addition to her numerous career accomplishments, Ms. Connelly's values of commitment to patients, integrity, transparency and respect are widely heralded among all who know her.  Women leaders like Ms. Connelly serve as role models for all women in the healthcare industry, demonstrating first-hand the contributions we can all make to society."  

Ms. Connelly joined GlaxoSmithKline in February 2009, where she leads an organization of approximately 10,000 employees and over $14 billion in sales. As part of her current responsibilities, she helps shape the future of the company as a member of its global corporate executive team and co-chairs its research portfolio management board. Prior to joining GlaxoSmithKline last year, Ms. Connelly spent 24 years with
'/>"/>

SOURCE Healthcare Businesswomen's Association (HBA)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. GlaxoSmithKline Accelerates Review of Exelixis XL880
3. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
4. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
5. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
6. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
7. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
8. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
9. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
10. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
11. Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015  Lannett Company, Inc. (NYSE: LCI ) ... Canaccord Genuity 35th Annual Growth Conference on Wednesday, August ... Boston Hotel.  A webcast of the ... are encouraged to visit the web site at least ... to register, download and install any necessary software.  The ...
(Date:7/30/2015)... , July 30, 2015  Cleave Biosciences ... Trademark Office has granted the company a key ... Cleave,s lead molecule CB-5083. This newly ... inhibitors of p97," U.S. 9,062,026, allows for claims ... first-in-class, highly selective oral inhibitor of p97, a ...
(Date:7/30/2015)... 30, 2015 Flexpoint Ford, a private equity ... today announced that it has entered into a partnership ... to form Kastle Therapeutics, LLC (Kastle).  The new ... focus on acquiring, developing and commercializing pharmaceuticals targeted toward ... include select therapies already approved for marketing, as well ...
Breaking Medicine Technology:Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3
... Alsius Corporation,(Nasdaq: ALUS ), the worldwide leader ... four scientific,posters featuring both patient cases and laboratory ... be presented this week at the American,Society of ... Dr. Arie Blitz, Director of Heart Transplantation ...
... Trial Results Disclosed, SAN DIEGO, Oct. ... developing "Best-in-Class" drugs for the,treatment of serious ... multiple studies on its lead program, TR-701, ... in eighteen presentations at the upcoming joint,Interscience ...
Cached Medicine Technology:Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting 2Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting 3Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA 2Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA 3
(Date:7/30/2015)... ... July 30, 2015 , ... ... I am Fine, an app invention that can help people during emergencies. , ... Scott Cooper, CEO and Creative Director of World Patent Marketing. "Currently, there are ...
(Date:7/30/2015)... ... July 30, 2015 , ... In an effort to provide the twenty ... making a change in his practice. , The decision will also allow him to ... Aggarwal will be transferring his in-patient admissions to the hospitalists at East Liverpool City ...
(Date:7/30/2015)... ... 30, 2015 , ... In a meaningful ritual intended to symbolize a final ... Center have created an addiction graveyard. Sharing this with the public comes at a ... Rocky Hudson . Hudson (1945-2015) fell in love with the desert when he moved ...
(Date:7/30/2015)... ... 30, 2015 , ... Google recently announced that it will be disclosing any ... in a June 8, 2015 article published by Nasdaq , the powerful tech ... by its computer-driven cars, which such industry players as Tesla CEO Elon Musk believe ...
(Date:7/30/2015)... ... July 30, 2015 , ... 24/7 Care At Home, ... and San Bernardino, recently announced that the Centers for Medicare and Medicaid (CMS) have ... home health care providers. 24/7 Care At Home’s agency is one of three top ...
Breaking Medicine News(10 mins):Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 3Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2
... Wellness through Education and Research InitiativesNEW YORK, April ... as a leadership contributor with the National Thoroughbred ... partnership,s aim is to ensure the health and ... accreditation program are addressed in a manner that ...
... Attention to Connecticut,s Growing Burden of Chronic Disease and Promote ... by CrisisHARTFORD, Conn., April 6 National and state health ... launch a Partnership to call for comprehensive health and economic ... in Connecticut and across the nation. , , ...
... Studies will chart recovery of active women with breast ... -- A Yale professor has received $7 million in ... ovarian and breast cancer recovery. , The U.S. ... that exercise along with traditional courses of treatment can ...
... identifies a protein that modifies the androgen receptor (AR) and ... progression of prostate cancer. The research, published by Cell Press ... Cell , may also drive creation of new strategies for ... to traditional anti-hormone therapies. , The AR is an ...
... joke that gets all the laughs. As funny as folks ... That,s one conclusion of a groundbreaking new paper from the ... the University of Toronto,s Rotman School of Management and the ... authors looked at the effect of sexual behavior in the ...
... is sweeping the countryCORDOVA, Tenn., April 6 Christian Companion ... practical and spiritual assistance, is opening an office in Cordova, ... The new office is located at 1160 Vickery Lane, Suite ... 1:30 p.m. and will last until 3:30 p.m. Free refreshments ...
Cached Medicine News:Health News:Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance 2Health News:Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance 3Health News:Bipartisan CT Coalition Forms to Fight Spiraling Health Care Costs 2Health News:Yale Plans Closer Look at Exercise and Cancer 2Health News:A potential new target for treatment of hormone refractory prostate cancer 2
... Immunoassay Control is a ... designed to complement the ... Immunoassay Plus Controls. This ... to include more complex ...
Liquichek Hematology-8 Control is a whole blood hematology control with extended stability for non-differential analyzers....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products: